Educational comparison of Muse cell therapy vs PRP therapy. Cover: mechanism differences (autologous platelet growth factors vs allogeneic pluripotent stress-enduring cells), what published evidence exists for each, when a physician might consider one vs the other, and honest limitations of both. Cite Dezawa characterization, Yamada 2018 homing, and note PRP's larger evidence base. Name Dr. Charles Pereyra, MD. 3-4 FAQ H3s. No superiority claims — let the science speak. Hedged, FDA disclaimer. ~700 words.
